3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase NA
1
Phase EARLY_PHASE1
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Polycystic Ovary Syndrome
52
Insulin Resistance
12
Metabolic Syndrome
4
Hyperandrogenism
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Obesity
3
Breast Neoplasms
3
Weight Loss
2
Rare Diseases
2
Infertility, Female
2
Hyperinsulinism
2
Endocrine System Diseases
2
Thyroid Nodule
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms
1
Premature Birth
1
Obesity, Morbid
1
Metformin
1
Menstruation Disturbances
1
Inflammation
1
Infertility
1
Hyperglycemia
1
Head and Neck Neoplasms
1
Glucose Intolerance
1
Endometrial Neoplasms
1
Diabetes Mellitus
1
Depression
1
Interventions
Surveys and Questionnaires
14
Low-Level Light Therapy
13
Standard of Care
11
Radiotherapy
11
Magnetic Resonance Spectroscopy
10
Radiotherapy, Intensity-Modulated
8
Exercise
8
Blood Specimen Collection
8
Magnetic Resonance Imaging
7
Cisplatin
6
Radiosurgery
5
Immunohistochemistry
5
Fluorodeoxyglucose F18
5
Biopsy
5
X-Rays
4
Transcutaneous Electric Nerve Stimulation
4
Therapeutics
4
Radiation
4
Practice Guidelines as Topic
4
Methods
4
Equipment and Supplies
4
Educational Status
4
Cetuximab
4
fluoromisonidazole
3
Tomography, X-Ray Computed
3
Resistance Training
3
Radiotherapy, Image-Guided
3
Preoperative Exercise
3
Positron-Emission Tomography
3
Nicotine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Head and Neck Neoplasms
×
Metformin
×
Clear all
NCT03510390
2021-11-18
HEAD-MET
Insel Gruppe AG, University Hospital Bern
Phase NA
Completed
17 enrolled